Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Report
|
This report provides an analysis of the orphan drug market. It comprises brands that have gained US FDA orphan drug approval, as well as Phase III pipeline candidates that have gained an orphan drug designation from the FDA.
Published By Datamonitor
|
08 Jan 2013 |
$3500
|
Report
|
Analysis of the treatment dynamics in postherpetic neuralgia (PHN). Contains analyses of presentation, diagnosis and treatment rates, and prescribing trends across the seven major markets using Datamonitor’s primary research of 131 physicians.
Published By Datamonitor
|
13 Nov 2012 |
$7600
|
Report
|
Datamonitor uses a patient-based approach to size the commercial potential of Alzheimer’s disease across the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK) from 2011 to 2021.
Published By Datamonitor
|
25 Oct 2012 |
$11400
|
Report
|
In-depth analysis of key brands and pipeline agents indicated for the treatment of Alzheimer’s disease. Provides a comparative evaluation of clinical and commercial drug attributes to determine competitiveness in the marketplace.
Published By Datamonitor
|
05 Oct 2012 |
$11400
|
Report
|
Review of key trends in the chronic nociceptive pain pipeline. Includes a detailed analysis of clinical trial design, target product profile, innovative early-stage approaches and future treatment developments.
Published By Datamonitor
|
21 Sep 2012 |
$3800
|
Report
|
Assessment of the current and future top 10 neurology brands using a sales-based forecasting methodology. The analysis is designed to understand the future dynamics of the branded neurology market, with a particular focus on leading therapies.
Published By Datamonitor
|
20 Sep 2012 |
$11400
|
Report
|
CNS drugs are associated with longer development times and higher attrition rates than drugs for other therapy areas. Advances in delivery technologies are essential if the pursuit of novel CNS treatments is to remain commercially viable.
Published By Datamonitor
|
05 Sep 2012 |
$3800
|
Report
|
CNS drugs are associated with longer development times and higher attrition rates than drugs for other therapy areas. Advances in delivery technologies are essential if the pursuit of novel treatments is to remain commercially viable.
Published By Datamonitor
|
05 Sep 2012 |
$3800
|
Report
|
Favorable legislation and recent commercial successes have stimulated growing interest in the discovery of novel orphan drugs. However, there are many strategic considerations that are peculiar to the R&D process for diseases of low prevalence.
Published By Datamonitor
|
31 Aug 2012 |
$3800
|
Report
|
This report analyzes the unmet needs of bipolar disorders treatment and the attributes of drugs that influence the prescribing decisions made by psychiatrists across the seven major markets.
Published By Datamonitor
|
30 Jul 2012 |
$3800
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.